Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury

Ítems similars

• Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19
  per: Kow, Chia Siang, et al.
  Publicat: (2020)
• Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury
  per: Kow, Chia Siang, et al.
  Publicat: (2020)
• Do the meta-analyses provide a clean bill of health to the use of renin-angiotensin system inhibitors in COVID-19?
  per: Kow, Chia Siang, et al.
  Publicat: (2020)
• Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
  per: Kow, Chia Siang, et al.
  Publicat: (2021)
• Use of DPP-4 inhibitors in patients with COVID-19
  per: Kow, Chia Siang, et al.
  Publicat: (2020)